Related Experiment Video
Updated: Jan 2, 2026

Three-Dimensional Printing of a Complex Aortic Anomaly
Published on: November 1, 2018
Diverticulosis today
Walter Elisei1, Giovanni Brandimarte2, Antonio Tursi3
1Division of Gastroenterology, ASL Roma 6, Albano Laziale, Rome, Italy.
Diverticular disease is rising globally, posing a significant healthcare cost. While some treatments help uncomplicated cases, effective strategies to prevent acute diverticulitis recurrence are still needed.
Area of Science:
- Gastroenterology
- Colorectal Diseases
Background:
- Diverticulosis and diverticular disease of the colon are increasing worldwide.
- This condition represents a substantial burden on healthcare systems due to direct and indirect costs.
Purpose of the Study:
- To review current understanding and treatment of colonic diverticular disease.
- To highlight the lack of robust evidence for preventing acute diverticulitis recurrence.
- To emphasize the emerging focus on endoscopic classification for guiding therapeutic approaches.
Main Methods:
- Literature review of existing studies on diverticular disease management.
- Analysis of current treatment strategies for symptomatic and uncomplicated cases.
- Discussion of emerging trends in disease classification and therapeutic evaluation.
Main Results:
- Fiber, non-absorbable antibiotics, and probiotics show effectiveness in treating symptomatic, uncomplicated diverticular disease.
- 5-aminosalicylic acid may aid in preventing acute diverticulitis.
- Robust evidence for medical strategies to prevent acute diverticulitis recurrence is currently lacking.
Conclusions:
- Current treatments offer benefits for uncomplicated diverticular disease but do not fully address recurrence prevention.
- Further research is needed to establish effective long-term management strategies.
- Development of a new endoscopic classification is crucial for optimizing therapeutic decisions and evaluating treatment outcomes.
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Other Disorders of Digestive System
Gastrointestinal Motility Disorders

